Cepton Technologies’ Helius™ Smart Lidar System Recognized as a CES 2020 Innovation Awards Honoree
Cepton Technologies, Inc. today announced its Helius™ Smart Lidar System has been named a CES® 2020 Innovation Awards Honoree. The CES Innovation Awards program by the Consumer Technology Association (CTA)® is a prestigious global competition held annually to honor outstanding design and engineering in consumer technology products across a wide range of categories. This year, Helius is honored in two categories: Tech for a Better World, which highlights product innovations aiming to make positive social and global impacts; and Smart Cities, recognizing technologies and applications designed to improve urban experiences with increased intelligence. This recognition validates Cepton’s commitment to bringing intelligent lidar solutions to a variety of industries to help build a safer, smarter world.
Helius, Cepton’s state-of-the-art lidar solution, delivers advanced object detection, tracking and classification capabilities to enable a wide range of applications for smart cities, transport infrastructure, security and more. It embodies an unprecedented fusion of three cutting-edge technologies: industry-leading 3D lidar sensing powered by Cepton’s patented Micro Motion Technology (MMT™); edge computing for minimum data burden and maximum ease of integration; and built-in advanced perception software for real-time analytics. This groundbreaking system not only leverages Cepton’s leading advantages in developing long range, high resolution and cost-efficient lidar, but also opens up the door to a variety of applications where data privacy can be protected by Helius’ anonymous scanning and analytics.
Helius provides centimeter-accurate 3D sensing of the dimension, location and velocity of objects, regardless of lighting conditions, and can collect and process data from multiple sensors for seamless object tracking across sensor coverage zones. As Helius does not capture, show or store any biometric and otherwise identifying data, it aims to maximize protection of people’s privacy while being installed as part of various smart cities and security systems. A few of Helius’ many use cases include:
Security and public safety: Helius enables intrusion detection, access control and behavior tracking to protect people and assets in public venues, critical infrastructure, construction zones, ports and airports, and manufacturing facilities. It also enables platform safety at train and metro stations. Helius’ anonymized surveillance allows it to work in a wide range of HIPAA and ADPR compliant spaces such as schools and hospitals.
Smart intersections and traffic management: Helius can help ensure safety and efficiency at road intersections and railway crossings by monitoring pedestrians and vehicles. It can also provide information on traffic density and patterns to automate traffic lights and enable route optimization.
Transport infrastructure: Helius can track vehicles to provide accurate and real-time information to optimize parking management in cities. It can profile vehicles and survey the road surface to evaluate potential road surface damage and to help automate tolling by classifying different types of vehicles passing at highway speeds.
Crowd analytics for large private and public venues: Helius can provide valuable anonymized information about how consumers navigate through retail stores, parks, stadiums and other venues and how they engage with advertisements and products on display. It can be used to track the occupancy of streets and buildings to automate lights, HVAC and other appliances to help preserve energy. Urban planners can rely on Helius to better understand how people move around and interact with public amenities and identify the impact of construction projects.
“Helius is a true game changer, combining lidar with edge computing and advanced perception software to help advance the transformation of smart cities, such as making transportation more efficient, increasing safety and enabling anonymized crowd analytics,” said Neil Huntingdon, VP Business Development at Cepton. “With its superior performance, cost efficiency and easy configuration, Helius will help usher in the transition from 2D to 3D perception as more companies and cities take advantage of this intelligent lidar system.”
Cepton will be showcasing the Helius Smart Lidar System at Tabletop No. 431 at the official CES pre-show media event, CES Unveiled Las Vegas, on Jan. 5, 2020, 5 – 8:30 p.m. PST. Helius will also be on display at the Innovation Awards Showcase in the Venetian Ballroom during CES.
During CES 2020 Jan. 7 – 10, 2020, Cepton will be exhibiting at booth No. 2501 at Westgate Las Vegas. Please stop by Cepton’s booth to learn more about Helius and the company’s full portfolio of high performance, reliable, scalable and cost-efficient lidar solutions for automotive, security, smart cities, transport infrastructure, crowd analytics, mapping, IoT and industrial applications.
For more information about Cepton Technologies Inc., visit www.cepton.com
About Cepton Technologies, Inc.
Cepton Technologies, Inc. is a 3D sensing solutions provider shipping state-of-the-art lidar products for the automotive, security, transport infrastructure, industrial, IoT and mapping markets.
Founded in 2016 and led by industry veterans with deep experience in lidar and advanced imaging, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions for the automotive industry and beyond.
Cepton’s patented lidar technology delivers outstanding detection range and resolution, reliability and affordability, to enable perception for the fast-growing market for autonomous and smart machines.
Cepton is headquartered in San Jose, California, USA. It also has registered offices in Germany, Canada and UK.
For more information, visit: www.cepton.com
About CES:
CES® is the largest, most influential tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector. Learn more at CES.tech and follow CES on social.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191107006092/en/
Contact information
Media Contact: Faithy Li, Cepton Technologies, media@cepton.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom